Ads
related to: Psoriatic Arthritis- Before & After
See Results In Photos Of
Real Patients.
- About Psoriasis
Information On Plaque Psoriasis
& Options Available For Treatment.
- Register For Support
Understand Your Options To Make
Treatment Affordable & Accessible.
- Patient Resources
Get Tools, Personalized Info,
Talk to a Nurse and More.
- About Plaque Psoriasis
Information On Plaque Psoriasis.
Learn About A Therapy Option.
- Therapy Information
Alternate Therapy For Plaque
Psoriasis.
- Before & After
Search results
Johnson & Johnson (NYSE:JNJ) Shares Bought by BI Asset Management Fondsmaeglerselskab A S
ETF DAILY NEWS· 7 days agoBI Asset Management Fondsmaeglerselskab A S lifted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 59.0% in the 4th quarter, according to the company in its most recent 13F filing ...
Johnson & Johnson (NYSE:JNJ) Trading Down 1.1%
ETF DAILY NEWS· 3 days agoShares of Johnson & Johnson (NYSE:JNJ – Get Free Report) were down 1.1% during mid-day trading on Thursday . The company traded as low as $151.70 and last traded at $151.81. Approximately 1,428,737 ...
Dynamic Technology Lab Private Ltd Reduces Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoDynamic Technology Lab Private Ltd decreased its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 59.3% during the 4th quarter, according to the company in its most recent ...
Johnson & Johnson (NYSE:JNJ) Stock Rating Reaffirmed by Royal Bank of Canada
ETF DAILY NEWS· 4 days agoJohnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a report issued on Wednesday, Benzinga reports.
Jump Financial LLC Has $369,000 Stock Position in Acelyrin, Inc. (NASDAQ:SLRN)
ETF DAILY NEWS· 3 days agoJump Financial LLC lifted its stake in shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) by 152.7% during the fourth quarter, according to the company in its most recent filing with the Securities ...
AltruBio, after tweaking checkpoint drug, raises $225M for midphase ulcerative colitis program
FierceBiotech· 7 days agoAltruBio has roared back after another pivot in its twisty history, securing up to $225 million in series B funding to take an immune checkpoint enhancer through a midphase ulcerative colitis ...
Robeco Institutional Asset Management B.V. Sells 501,987 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 days agoRobeco Institutional Asset Management B.V. reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 41.0% during the fourth quarter, according to its most recent 13F filing with the ...
MainStreet Investment Advisors LLC Cuts Stock Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoMainStreet Investment Advisors LLC trimmed its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 2.7% during the 4th quarter, according to its most recent filing with the Securities ...
Cornerstone Advisors LLC Sells 7,098 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoCornerstone Advisors LLC trimmed its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities ...
Ad
related to: Psoriatic Arthritis